Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth

Drug-induced gingival overgrowth is a frequently observed adverse effect of antihypertensive drug calcium channel blockers (CCBs). Gingival enlargements are more common with the dihydropyridine class of CCBs. The fourth-generation dihydropyridine CCB Cilnidipine was introduced in 1995 and is used as...

Full description

Bibliographic Details
Main Authors: Sameera Gopinath, Vadakkedath Venugopal Harishkumar, Vediyera Chandroth Santhosh, Sreekanth Puthalath
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Indian Society of Periodontology
Subjects:
Online Access:http://www.jisponline.com/article.asp?issn=0972-124X;year=2019;volume=23;issue=4;spage=377;epage=380;aulast=Gopinath
_version_ 1818296407722819584
author Sameera Gopinath
Vadakkedath Venugopal Harishkumar
Vediyera Chandroth Santhosh
Sreekanth Puthalath
author_facet Sameera Gopinath
Vadakkedath Venugopal Harishkumar
Vediyera Chandroth Santhosh
Sreekanth Puthalath
author_sort Sameera Gopinath
collection DOAJ
description Drug-induced gingival overgrowth is a frequently observed adverse effect of antihypertensive drug calcium channel blockers (CCBs). Gingival enlargements are more common with the dihydropyridine class of CCBs. The fourth-generation dihydropyridine CCB Cilnidipine was introduced in 1995 and is used as an antihypertensive agent for patients in the Indian subcontinent. This is the first report in literature to document an isolated case of generalized gingival overgrowth induced by the long-term use of low dose of cilnidipine in an elderly female patient who is under antihypertensive therapy. Gingival overgrowth is an adverse drug reaction of new-generation CCB Cilnidipine when administered even as low-dose antihypertensive therapy agent. Physicians and dentists should identify such late changes in susceptible individuals.
first_indexed 2024-12-13T04:03:03Z
format Article
id doaj.art-2e52faf618124c238dd9c7329869162d
institution Directory Open Access Journal
issn 0972-124X
language English
last_indexed 2024-12-13T04:03:03Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Indian Society of Periodontology
spelling doaj.art-2e52faf618124c238dd9c7329869162d2022-12-22T00:00:21ZengWolters Kluwer Medknow PublicationsJournal of Indian Society of Periodontology0972-124X2019-01-0123437738010.4103/jisp.jisp_557_18Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowthSameera GopinathVadakkedath Venugopal HarishkumarVediyera Chandroth SanthoshSreekanth PuthalathDrug-induced gingival overgrowth is a frequently observed adverse effect of antihypertensive drug calcium channel blockers (CCBs). Gingival enlargements are more common with the dihydropyridine class of CCBs. The fourth-generation dihydropyridine CCB Cilnidipine was introduced in 1995 and is used as an antihypertensive agent for patients in the Indian subcontinent. This is the first report in literature to document an isolated case of generalized gingival overgrowth induced by the long-term use of low dose of cilnidipine in an elderly female patient who is under antihypertensive therapy. Gingival overgrowth is an adverse drug reaction of new-generation CCB Cilnidipine when administered even as low-dose antihypertensive therapy agent. Physicians and dentists should identify such late changes in susceptible individuals.http://www.jisponline.com/article.asp?issn=0972-124X;year=2019;volume=23;issue=4;spage=377;epage=380;aulast=GopinathAdverse drug reactioncalcium channel blockercilnidipinedihydropyridinegingival overgrowth
spellingShingle Sameera Gopinath
Vadakkedath Venugopal Harishkumar
Vediyera Chandroth Santhosh
Sreekanth Puthalath
Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
Journal of Indian Society of Periodontology
Adverse drug reaction
calcium channel blocker
cilnidipine
dihydropyridine
gingival overgrowth
title Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
title_full Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
title_fullStr Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
title_full_unstemmed Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
title_short Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
title_sort case report on low dose of cilnidipine a fourth generation calcium channel blocker induced gingival overgrowth
topic Adverse drug reaction
calcium channel blocker
cilnidipine
dihydropyridine
gingival overgrowth
url http://www.jisponline.com/article.asp?issn=0972-124X;year=2019;volume=23;issue=4;spage=377;epage=380;aulast=Gopinath
work_keys_str_mv AT sameeragopinath casereportonlowdoseofcilnidipineafourthgenerationcalciumchannelblockerinducedgingivalovergrowth
AT vadakkedathvenugopalharishkumar casereportonlowdoseofcilnidipineafourthgenerationcalciumchannelblockerinducedgingivalovergrowth
AT vediyerachandrothsanthosh casereportonlowdoseofcilnidipineafourthgenerationcalciumchannelblockerinducedgingivalovergrowth
AT sreekanthputhalath casereportonlowdoseofcilnidipineafourthgenerationcalciumchannelblockerinducedgingivalovergrowth